OGT Launches Myeloid MRD Panel for Sensitive AML Biomarker Detection
OGT's SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Category: Leukemia
Leukemia
Latest
Leukemia
Latest
Alercell Spearheads Development of Leukemia Diagnostic Test
Alercell's leukemia test will use terminal erythroid differentiation for prognostic classification in patients with myeloid malignancies.
Leukemia
Latest
Alercell Launching Leukemia Diagnostic Test
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
BioFluidica to Commericalize LiquidScan Biopsy System
BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.Â
Read More
Qlucore Awarded Grant to Aid Clinical Diagnostics of Cancer
The grant will allow Qlucore to expand Qlucore Diagnostics software with a focus on RNA-profiling of glioma and acute leukemia.
Read More
Study Demonstrates New Tool for Rapid Evaluation of Acute Leukemia Patients
PixCell’s HemoScreen may be used to monitor pathological blood samples, improving treatment process for hematological patients.
Read More
Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read More
Study Offers Promise for Early Detection of Infections among Childhood Leukemia Patients
A noninvasive blood test may provide a ‘crystal ball’ for early detection of infections, leading to increased cure rates among pediatric leukemia patients.
Read More
Interventional Study to Evaluate Multicancer Early Detection Test
The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.
Read More
OGT Updates SureSeq NGS Portfolio
The latest update is beneficial to researchers investigating myeloid disorders, and is now enabled with BCR-ABL fusion gene and KMT2A-PTD detection.
Read More
Study Offers Promise for Multicancer Detection from a Single Blood Draw
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read More
OGT Releases NGS Panel for Somatic CNV Detection in Chronic Lymphocytic Leukemia
The panel has been tested to show excellent concordance with array data, and can detect both small and large CNVs, indels, LOH, and SNVs.
Read More
FDA Clears Analyzer for Fingerstick Blood Testing
Sight Diagnostics’ patented Olo analyzer digitizes blood into images to perform the most common blood test in minutes, using just two drops of blood.
Read MoreNGS Detects Bloodstream Infections in Pediatric Cancer Patients before Symptoms Develop
The Karius test detected bloodstream infections in 75% of cases as early as 3 days before pediatric leukemia patients became symptomatic.
Read More
Elevating Pathology
AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.
Read More
Preliminary Data Confirm Saphyr’s Potential to Replace Traditional Cytogenetics Methods for Detecting Structural Variants in Certain Blood Cancers
Strong concordance with standard-of-care methods shows how the Saphyr mapping system can transform cytogenetic workflows and improve blood cancer treatment.
Read More
Liquid Biopsies Guide Improved Cancer Treatment
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read MoreSaga Raises $4.1 Million to Advance Ultrasensitive Liquid Biopsies
The funds will be used to accelerate commercialization of Saga’s portfolio of kits and services, continue development of new products, and perform prospective clinical studies.
Read More